A Clinical Monitoring System for Clozapine-Reference-Cited by-同舟云学术

A Clinical Monitoring System for Clozapine

Published:2006-06 Issue:2 Volume:14 Page:156-168
ISSN:1039-8562
Container-title:Australasian Psychiatry
language:en
Short-container-title:Australas Psychiatry

Author:

Castle David¹,Lambert Tim²,Melbourne Sue³,Cox Andrew⁴,Boardman Gaylene⁵,Fairest Katherine⁶,Davy Martin⁷,Goh Joyce⁸,Kuluris Bill⁹,Berk Michael¹⁰

Affiliation:

1. Chair of Psychiatry, St Vincent's Hospital, Fitzroy, Vic., Australia

2. Associate Professor and Director, Office for Psychiatric Evaluation and Educational Newmedia, University of Melbourne; and Consultant Psychiatrist, Orygen Youth Health, Parkville, Vic., Australia.

3. Pharmacist, Sunshine Hospital, Sunshine, Vic., Australia

4. Pharmacist, Royal Melbourne Hospital, Melbourne, Vic., Australia

5. Clozapine Coordinator, WidWest AMHS, Sunshine; and Lecturer, Victoria University, St Albans, Vic., Australia.

6. Clozapine Coordinator, MidWest AMHS, Sunshine, Vic., Australia.

7. Clozapine Coordinator, Northern AMHS, Melbourne, Vic., Australia.

8. Manager, Planning and Quality, North Western Mental Health, Melbourne, Vic., Australia

9. Clozapine Coordinator, Barwon Health, Geelong, Vic., Australia

10. Professor, University of Melbourne and Barwon Health, Geelong, Vic., Australia

Abstract

Objective: To describe a framework for the initiation and ongoing monitoring of patients on clozapine, and detail support materials that can be used in clinical settings, including general practice, to support this process. Conclusions: A framework is described. Clozapine has a special place in the management of treatment-resistant schizophrenia. However, it has certain side-effects that require its use to be carefully evaluated on an individual patient basis, and encompass excellent documentation and discussion with all relevant parties. Comprehensive longitudinal monitoring is required.

Publisher

SAGE Publications

Subject

Psychiatry and Mental health

Link

http://journals.sagepub.com/doi/pdf/10.1080/j.1440-1665.2006.02267.x

Reference19 articles.

1. Clozapine

2. Psychopharmacological management of schizophrenia

3. A review of clozapine safety

4. Metabolic Syndrome in Patients With Schizophrenia

5. Body Mass Index in Persons with Schizophrenia

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transitioning from Hospital-Based Care to Community-Based Models of Care;Schizophrenia Treatment Outcomes;2020

2. A state-wide quality improvement system utilising nurse-led clinics for clozapine management;Australasian Psychiatry;2014-05-08

3. Demonstrating the effectiveness of less restrictive care pathways for the management of patients treated with clozapine;Australasian Psychiatry;2013-07-29

4. What is needed to deliver collaborative care to address comorbidity more effectively for adults with a severe mental illness?;Australian & New Zealand Journal of Psychiatry;2012-10-17

5. Psychopharmacological management of schizophrenia;Pharmacological and Psychosocial Treatments in Schizophrenia, Third Edition;2012-09-20